Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

P2X7 Blockade Attenuates Murine Lupus Nephritis by Inhibiting Activation of the NLRP3/ASC/Caspase 1 Pathway

Open access
Zhao, Jijun, Wang, Hongyue, Dai, Chao, Wang, Hongyang, Zhang, Hui, Huang, Yuefang, Wang, Shuang, Gaskin, Felicia, Yang, Niansheng, Man Fu, Shu·2013·Arthritis & Rheumatism

Abstract

Objective: The NLRP3 inflammasome plays key roles in inflammation and autoimmunity, and purinergic receptor P2X 7 has been proposed to be upstream of NLRP3 activation. The aim of the present study, using murine models, was to investigate whether the P2X 7/NLRP3 inflammasome pathway contributes to the pathogenesis of lupus nephritis (LN). Methods: MRL/lpr mice were treated with the selective P2X 7 antagonist brilliant blue G (BBG) for 8 weeks. Following treatment, the severity of renal lesions, production of anti–double‐stranded DNA (anti‐dsDNA) antibodies, rate of survival, activation of the NLRP3/ASC/caspase 1 inflammasome pathway, and ratio of Th17 cells to Treg cells were evaluated. P2X 7‐targeted small interfering RNA (siRNA) was also used for in vivo intervention. Similar evaluations were carried out in NZM2328 mice, a model of LN in which the disease was accelerated by administration of adenovirus‐expressing interferon‐α (AdIFNα). Results: Significant up‐regulation of P2X 7/NLRP3 inflammasome signaling molecules was detected in the kidneys of MLR/lpr mice as compared with normal control mice. Blockade of P2X 7 activation by BBG suppressed NLRP3/ASC/caspase 1 assembly and the subsequent release of interleukin‐1β (IL‐1β), resulting in a significant reduction in the severity of nephritis and circulating anti‐dsDNA antibodies. The lifespan of the treated mice was significantly prolonged. BBG treatment reduced the serum levels of IL‐1β and IL‐17 and the Th17:Treg cell ratio. Similar results were obtained by specific siRNA silencing of P2X 7 in vivo. The effectiveness of BBG treatment in modulating LN was confirmed in NZM2328 mice with AdIFNα‐accelerated disease. Conclusion: Activation of the P2X 7 signaling pathway accelerates murine LN by activating the NLRP3/ASC/caspase 1 inflammasome, resulting in increased IL‐1β production and enhanced Th17 cell polarization. Thus, targeting of the P2X 7/NLRP3 pathway should be considered as a novel therapeutic strategy in patients with lupus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.38174

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 192

Metadata

Authors
Zhao, J., Wang, H., Dai, C., Wang, H., Zhang, H., Huang, Y., Wang, S., Gaskin, F., Yang, N., & Man Fu, S.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2013-11-27
Volume
65
Issue
12
Pages
3176-3185
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1918150899
Cited by
192
References
3
FWCI
12.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: P2X7 Blockade Attenuates Murine Lupus Nephritis by Inhibiting Activation of the NLRP3/ASC/Caspase 1 Pathway. https://app.cochat.ai/papers/10.1002/art.38174
The paper
Zhao, J., Wang, H., Dai, C., Wang, H., Zhang, H., Huang, Y., Wang, S., Gaskin, F., Yang, N., & Man Fu, S. (2013). P2X7 Blockade Attenuates Murine Lupus Nephritis by Inhibiting Activation of the NLRP3/ASC/Caspase 1 Pathway. Arthritis & Rheumatism. https://doi.org/10.1002/art.38174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.